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These  maps  show  the  geographic  variation  of  standardized  per  capita
Medicare spending, in US dollars, for all covered services among Medicare
fee-for-service beneficiaries with 6 or more chronic conditions, United States,
2014. The maps highlight the need for targeted chronic disease prevention
programs and policies in areas with the highest levels of Medicare spending.
 
Background
The prevalence of Medicare beneficiaries aged 65 years or older
with 6 or more concurrent chronic conditions (MCC6+) varies
geographically  (1).  Preventing chronic  disease  costs  less  than
treating it. Chronic diseases that are well managed progress slower
than those that are untreated (2). Thus, understanding how Medi-
care spending is distributed across the United States among older
adults with the highest burden of multiple chronic conditions can
assist with targeting prevention and disease management efforts.
The objective of this analysis was to describe the county-level
variation in per capita Medicare spending among MCC6+ benefi-
ciaries.
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Methods
We estimated per capita Medicare spending for MCC6+ benefi-
ciaries aged 65 years or older by county using Centers for Medi-
care and Medicaid Services (CMS) enrollment and claims data for
100% of Medicare beneficiaries enrolled in the fee-for-service
(FFS) program in 2014 (3). We excluded Medicare Advantage be-
neficiaries because claims data were not available; we also ex-
cluded beneficiaries enrolled in Medicare Part A only or Part B
only, because their utilization was not comparable to those en-
rolled in both parts. The set of 19 chronic conditions examined —
1) hypertension, 2) hyperlipidemia, 3) arthritis, 4) ischemic heart
disease, 5) diabetes, 6) chronic kidney disease, 7) heart failure, 8)
depressive disorders, 9) chronic obstructive pulmonary disease 10)
Alzheimer disease and related dementias, 11) atrial fibrillation, 12)
cancer,  13)  asthma,  14)  stroke,  15)  osteoporosis,  16)  schizo-
phrenia, 17) HIV/AIDS, 18) hepatitis (chronic viral B and C), and
19) autism — were those included in CMS’s public use files and
that have been previously defined (4).  A beneficiary was con-
sidered to have a chronic condition if there were claims with dia-
gnosis codes indicating the beneficiary received a service or treat-
ment of the condition. The number of claim years searched varied
by condition as per previous methods (3).
Medicare spending included total Medicare payments for all Medi-
care-covered services in Parts A and B and was calculated per be-
neficiary (ie, per capita). Per capita Medicare spending in each
county was derived by dividing total Medicare spending among
the MCC6+ beneficiaries by the number of MCC6+ beneficiaries.
We use standardized payments  to  account  for  the  variation in
Medicare payments for the same service in different areas. Stand-
ardized payments do not adjust for differences in health status
among beneficiaries. More information on the standardization of
Medicare payments is available (5).
CMS suppresses data with fewer than 11 beneficiaries per cell
size. In this analysis, data on counties with fewer than 11 FFS be-
neficiaries with 6 or more conditions were suppressed (n = 38).
For those counties, we imputed the number of beneficiaries by tak-
ing the difference between the number of beneficiaries in the state
and the sum of beneficiaries in nonsuppressed counties, then dis-
tributing this difference equally across the suppressed counties in
the state. The imputation process for Medicare spending for sup-
pressed counties was similar, taking the difference between ag-
gregate spending for the MCC6+ beneficiaries in the state and the
sum of aggregate spending in nonsuppressed counties and distrib-
uting this difference equally across the suppressed counties in the
state. To calculate a more stable per capita spending value, we in-
cluded only counties that had at least 25 beneficiaries. For those
counties with more than 11 and fewer than 25 beneficiaries, we
calculated the distance from the center of each county to the cen-
ters of all other counties and used this distance to borrow cases
from the nearest set of neighboring counties necessary to gain 25
beneficiaries.  We classified  county-level  per  capita  Medicare
spending into quintiles.
We used global and local Moran’s I to test for spatial autocorrela-
tion (6) in per capita Medicare spending. Global methods indicate
that clustering has occurred while local methods identify where
the clusters were located. For both global and local measures, the
Moran’s I statistic has values that range from −1.0 to 1.0. Gener-
ally, a Moran’s I with a positive value indicates that neighboring
counties have similar values while dissimilar values are farther
away, and a Moran’s I with a negative value indicates that neigh-
boring counties have dissimilar values, like a checkerboard. For
this study, the global Moran’s I tested whether per capita spend-
ing tended to cluster in the continental United States (6). The loc-
al Moran’s I identified 1) counties whose neighbors tended to have
similar levels of spending, and 2) counties whose neighbors ten-
ded to have dissimilar levels of spending.
Main Findings
In 2014,  of  the 28 million FFS beneficiaries  aged 65 years  or
older, 4.3 million (15.4%) had 6 or more chronic conditions. Na-
tionally, Medicare spending for this group totaled $126.1 billion,
which  accounted  for  51%  of  Medicare  FFS  spending.  Mean
county spending was $28,811 per beneficiary (standard deviation,
$3,879). Map A shows geographic variation in per capita Medi-
care spending.
The Moran’s I was 0.2509 (P < .001) indicating that counties in
the continental United States with high spending levels tended to
have neighboring counties with high spending, while counties with
low spending levels tended to have neighboring counties with low
spending. These geographic clusters are shown in Map B. Dark
red areas are clusters in which counties with high spending are
surrounded by counties with high spending. Dark blue areas are
clusters  where  counties  with  low spending are  surrounded by
counties with low spending. Light red areas are counties with high
spending but are surrounded by counties with low spending. Light
blue areas are counties with low spending but are surrounded by
counties  with  high  spending.  Northern  Louisiana,  western
Alabama, northern Texas, and central Wyoming had the largest
geographic concentrations of high per capita spending. Other areas
with high spending were western Pennsylvania, Northeast Wis-
consin, northwest Michigan, western Oregon and Upstate New
York generally had low levels of spending.
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Action
These geographic differences in spending highlight the need to
identify factors associated with the geographic pattern of spend-
ing for MCC6+ beneficiaries. These include risk factors for and
costs associated with each of the 19 conditions and the most pre-
valent chronic conditions in a county. One approach to reduce
spending is preventing chronic disease through preventive health
care, public health policy, and public engagement in the noted
geographic areas; targeted chronic disease management programs
also could be beneficial in these areas, resulting in improved out-
comes and reduced costs. Future work could include an explora-
tion of beneficiaries’ care utilization patterns, such as the impact
of chronic disease care delivered in primary care, hospital, and
emergency settings on per-beneficiary costs.
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